Drug intelligence / Profile preview

HSPA8 siRNA knockdown

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intrathecal, Percutaneous
01

Overview

HSPA8 siRNA knockdown refers to the experimental use of small interfering RNA (siRNA) to selectively silence the expression of heat shock cognate 71 kDa protein (HSPA8, also known as Hsc70). HSPA8 is a constitutively expressed molecular chaperone belonging to the heat shock protein 70 (Hsp70) family, which plays a critical role in protein folding, transport, and chaperone-mediated autophagy. In preclinical research, knockdown of HSPA8 has been shown to inhibit cell proliferation, promote apoptosis, and suppress migration and xenograft growth in various cancer models, including breast cancer and endometrial carcinoma. It is primarily utilized as a research tool for target validation and functional characterization of HSPA8 in oncology and inflammatory diseases.

Other names
Hsc70 siRNAHsc-70 siRNAHsc 70 siRNAHsc70 siRNA knockdownHsc-70 siRNA knockdownHsc 70 siRNA knockdownHSPA8 siRNAHSPA-8 siRNAHSPA 8 siRNAHSPA8 small interfering RNAHSPA-8 small interfering RNAHSPA 8 small interfering RNA
02

Targets

HSPA8 (Heat shock cognate 71 kDa protein)Heat shock 70 kDa protein 1A mRNA

Beyond the preview

Go deeper on HSPA8 siRNA knockdown.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HSPA8 siRNA knockdown.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call